In-Hoo Kim
Overview
Explore the profile of In-Hoo Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
1425
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jang J, Lee M, Lee M, Myoung J, Lee H, Choi B, et al.
Cell Mol Life Sci
. 2025 Feb;
82(1):77.
PMID: 39951059
All cellular transcripts initially have a tri-phosphate (PPP) group at the 5'-end, recognized as a pathogen-associated molecular pattern (PAMP) by a cell's innate immune system. The removal of 5'-PPP occurs...
2.
Saruuldalai E, Lee H, Lee Y, Hong E, Ro S, Kim Y, et al.
Mol Ther Nucleic Acids
. 2024 Aug;
35(3):102270.
PMID: 39171141
Recombinant adenovirus (rAdV) vector is the most promising vehicle to deliver an exogenous gene into target cells and is preferred for gene therapy. Exogenous gene expression from rAdV is often...
3.
Choi S, Lee Y, Lee Y, Kim H, Kim W, Jung S, et al.
J Control Release
. 2023 Mar;
360:940-952.
PMID: 37001565
Owing to a lack of reliable markers and therapeutic targets, pancreatic ductal adenocarcinoma (PDAC) remains the most lethal malignant tumor despite numerous therapeutic advances. In this study, we utilized cell-SELEX...
4.
Saruuldalai E, Park J, Kang D, Shin S, Im W, Lee H, et al.
Mol Ther Oncolytics
. 2022 Mar;
24:683-694.
PMID: 35284627
Elucidation of the interplay between viruses and host cells is crucial for taming viruses to benefit human health. Cancer therapy using adenovirus, called oncolytic virotherapy, is a promising treatment option...
5.
Lee Y, Bao X, Lee H, Jang J, Saruuldalai E, Park G, et al.
Int J Mol Sci
. 2021 Mar;
22(4).
PMID: 33670458
Interferons (IFNs) are a crucial component in the innate immune response. Especially the IFN-β signaling operates in most cell types and plays a key role in the first line of...
6.
Choi E, Wu W, Zhang K, Lee I, Kim I, Lee Y, et al.
Front Mol Biosci
. 2021 Feb;
7:609732.
PMID: 33604354
Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infection in young children. However, effective treatment against RSV is unavailable. tRNA-derived RNA fragments (tRFs) are a...
7.
Kim H, Sung H, Lee Y, Choi S, Kim Y, Heo K, et al.
Int J Mol Sci
. 2020 May;
21(9).
PMID: 32384770
Antibody drug conjugates (ADCs), consisting of a cancer-specific antibody and cytotoxic payload, are shown to be a potent class of anticancer therapeutics, with enhanced therapeutic efficacy and reduced "off-target" side...
8.
Im W, Lee H, Lee Y, Lee J, Jang H, Kim S, et al.
Cells
. 2020 Apr;
9(4).
PMID: 32225025
nc886 is a regulatory non-coding RNA (ncRNA) whose expression is frequently silenced in malignancies. In the case of esophageal squamous cell carcinoma (ESCC), nc886 silencing is associated with shorter survival...
9.
Kunkeaw N, Lee Y, Im W, Jang J, Song M, Yang B, et al.
Proc Natl Acad Sci U S A
. 2019 Apr;
116(17):8289-8294.
PMID: 30948645
DNA-reactive compounds are harnessed for cancer chemotherapy. Their genotoxic effects are considered to be the main mechanism for the cytotoxicity to date. Because this mechanism preferentially affects actively proliferating cells,...
10.
Kim M, Kim I, Lim M, Kim Y, Park B
Cancer Epidemiol
. 2018 Dec;
58:130-136.
PMID: 30576983
Background: To compare the prevalence of metabolic syndrome (MeS) in cancer survivors returning to the community to that of non-cancer controls. Methods: We used baseline data from a nationwide cohort...